MEDIFAST INC (MED) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MEDIFAST INC (MED) has outperformed Niagen Bioscience (NAGE) over the past year, losing 17.2% versus a loss of 64.4%. Over five years, NAGE leads with a -57.7% price change compared with -93.9% for MED. Niagen Bioscience is the larger company by market cap ($212.8 million vs $129.8 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MED | NAGE |
|---|---|---|
| Share price | $11.61 | $2.69 |
| Market cap | $129.81M | $212.85M |
| 1-day change | +1.57% | +1.13% |
| YTD return | +8.71% | -57.70% |
| 1-year return | -17.25% | -64.42% |
| 5-year return | -93.92% | -57.70% |
| P/E ratio (TTM) | — | 14.16 |
| Forward P/E | — | 26.90 |
| EPS (TTM) | $-2.33 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.60 | $7.95 |
| 52-week low | $9.22 | $2.61 |
| Distance from 52-week high | -14.63% | -66.16% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +3.36% | +349.07% |
| Average volume | 147.80K | 583.55K |
| Shares outstanding | 11.18M | 79.13M |
| Employees | 380 | 117 |
| Sector | Consumer Staples | Health Care |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MED has outperformed NAGE by 47.2 percentage points over the past year.
- The two companies sit in different sectors: MEDIFAST INC in Consumer Staples and Niagen Bioscience in Health Care.
About MEDIFAST INC
MED stock →Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements.
Consumer Staples · Packaged Foods · 380 employees
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
MED vs NAGE FAQ
Which is bigger, MEDIFAST INC or Niagen Bioscience?
Niagen Bioscience (NAGE) is larger, with a market capitalization of $212.85M compared with $129.81M for MEDIFAST INC (MED).
Which stock has performed better over the past year, MED or NAGE?
MED returned -17.25% over the past 12 months, compared with -64.42% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are MEDIFAST INC and Niagen Bioscience in the same industry?
No. MEDIFAST INC is in the Consumer Staples sector, while Niagen Bioscience is in Health Care.